Dublin, April 09, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/tzk9dz/cancer_targeted) has announced the addition of the "Cancer Targeted Therapy Market & Clinical Insight 2015" report to their offering.
Cancer targeted therapeutics global market could be broadly divided into small and large molecules segments. Small molecules generate significant shares due to their sheer numbers as compared to large molecules cancer targeted therapeutics. Moreover, they have mature market and they could be considered as pioneer due to which they have more market penetration across the globe. Their prices have gone down because significant progress has been achieved in their drug design development, manufacturing and marketing. However, they have limited targeting efficacy and limited products could be used for multiple cancer indications. This scenario gave way to market introduction of large molecule cancer targeted therapeutics having better pharmacological profiles.
Clinical Insight on Cancer Targeted Therapies Pipeline Covered in Report:
- Cancer Targeted Tyrosine Kinase Inhibitors Pipeline: 388 TKI
- Cancer Targeted Angiogenesis Inhibitors Pipeline: 166 Angiogenesis Inhibitors
- Cancer Vaccines Pipeline: 289 Cancer Vaccines
- Cancer Targeted Monoclonal Antibodies: 605 mAb
- Oncogene Inhibitors Pipeline: 185 oncogene inhibitors
Cancer Targeted Therapy Market & Clinical Insight Report Highlight:
- Introduction & Categorization of Cancer Targeted Therapies
- Mechanism of Cancer Targeted Tyrosine Kinase, Vaccines, Oncogenes Inhibitors, Monoclonal Antibodies
- Cancer Targeted Therapy Clinical Pipeline by Company, Indication & Phase
- Clinical Insight on More Than 1200 Cancer Targeted Therapies in Pipeline
- Clinical Insight & Patent Analysis of Marketed Cancer Targeted Therapies
- Global Cancer Targeted Therapeutics Market Dynamics
- Future Prospects of Cancer Targeted Therapies
Key Topics Covered:
1. Introduction to Cancer Targeted Therapeutics
2. Need for Cancer Targeted Therapeutics
3. Categorization of Cancer Targeted Therapies
4. Consideration of Cancer Vaccines as Targeted Therapeutics
5. Mechanism of Cancer Vaccines
6. Mechanisms of Cancer Targeted Monoclonal Antibodies
7. Mechanism of Cancer Targeted Tyrosine Kinase Therapeutics
8. Mechanism of Oncogene Inhibitors
9. Global Cancer Targeted Therapy Market Overview
10. Global Cancer Targeted Therapeutics Market Dynamics
11. Future Prospects of Cancer Targeted Therapeutics
12. Cancer Targeted Monoclonal Antibodies Pipeline by Company, Indication & Phase
13. Marketed Cancer Monoclonal Antibodies by Indication, Company & Country
14. Global Cancer Vaccines Clinical Pipeline Insight by Company, Indication & Phase
15. Marketed Cancer Vaccines Clinical Insight by Indication, Company & Country
16. Oncogene Inhibitors Pipeline by Company, Indication & Phase
17. Marketed Oncogene Inhibitors by Company & Indication
18. Cancer Targeted Tyrosine Kinase Clinical Trial by Company, Indication & Phase
19. Marketed Cancer Targeted Tyrosine Kinase Inhibitors
20. Cancer Targeted Angiogenesis Inhibitors Therapy Pipeline by Company, Phase & Indication
21. Marketed Cancer Targeted Angiogenesis Inhibitors
22. Competitive Landscape
- Advaxis
- Bind Therapeutics
- Boehringer Ingelheim
- Bristol Mayer Squibb
- Celldex Therapeutics
- Dendreon Corporation
- Eli Lily
- GalaxoSmithKline
- Galena Biopharma
- Genetech
- ImmunoCellular Therapeutics
- ImmunoGen
- Inovio Pharmaceuticals
- Johnson & Johnson
- NeoStem Oncology
- NewLink Genetics
- Northwest Biotherapeutics
- Merck
- Novartis
- Peregrine Pharmaceuticals
- Pfizer
- Roche
- Sanofi
- Seattle Genetics
- Teva
For more information visit http://www.researchandmarkets.com/research/tzk9dz/cancer_targeted